Pemvidutide (TFA) is a dual GLP-1R/GCGR agonist used in metabolic disease research. It demonstrates efficacy in reducing body weight, hepatic steatosis, and improving lipid profiles in preclinical models, supporting its investigation for conditions like obesity and NASH.
Molecular Weight:
3873.35 (free base)
Formula:
C182H275N39O54.xC2HF3O2
Target:
Glucagon Receptor,Others
* VAT and and shipping costs not included. Errors and price changes excepted
